Page last updated: 2024-10-20

pyruvic acid and Glycogen Storage Disease Type I

pyruvic acid has been researched along with Glycogen Storage Disease Type I in 2 studies

Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.

Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jones, JG1
Garcia, P1
Barosa, C1
Delgado, TC1
Diogo, L1
Leonard, JV1

Other Studies

2 other studies available for pyruvic acid and Glycogen Storage Disease Type I

ArticleYear
Hepatic anaplerotic outflow fluxes are redirected from gluconeogenesis to lactate synthesis in patients with Type 1a glycogen storage disease.
    Metabolic engineering, 2009, Volume: 11, Issue:3

    Topics: Acetyl Coenzyme A; Adolescent; Carbon Isotopes; Child; Citric Acid Cycle; Female; Gluconeogenesis; G

2009
Problems in the congenital lactic acidoses.
    Ciba Foundation symposium, 1982, Volume: 87

    Topics: Acidosis; Child; Child, Preschool; Citric Acid Cycle; Female; Fructose-1,6-Diphosphatase Deficiency;

1982